NDATOPICALSOLUTION
Approved
Feb 1978
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Drug data last refreshed 23h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
GERMA-MEDICA MG is a topical solution containing hexachlorophene, approved in 1978 for treating staphylococcal infections. The drug is a small-molecule antimicrobial agent applied directly to affected skin surfaces. Its mechanism of action involves disruption of bacterial cell membranes, though detailed pharmacological specifics are not extensively documented in modern literature.
LOE Approaching
Product is approaching loss of exclusivity with moderate competitive pressure (30 score), suggesting potential team consolidation and declining headcount opportunities.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Why This Matters for Your Career
Medica Corp is hiring 2 roles related to this product
Worked on GERMA-MEDICA "MG" at Medica Corp? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.